Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Katherine Strei currently holds 62,824 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katherine Strei has been a net neutral trader of EBS stock. They have purchased $0 and sold $0 worth of shares.
Katherine Strei's most recent insider trade was on Feb 28, 2023, when they sold 690 shares at $12.38 per share.
Katherine Strei serves as Executive at Emergent BioSolutions Inc. (EBS). They have executed 36 insider transactions totaling $0 over their tenure at the company.
Katherine Strei holds the position of Executive at Emergent BioSolutions Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Katherine Strei has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Katherine Strei was on Feb 9, 2021, when they sold $252.1K worth of EBS shares. This transaction involved 2,042 shares at $123.45 per share.
Katherine Strei currently owns 62,824 shares of Emergent BioSolutions Inc. (EBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Katherine Strei's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Katherine Strei has 36 Form 4 filings on record as an insider at Emergent BioSolutions Inc..
Set alerts for Katherine Strei and 40,000+ other insiders.